Research & Development
Central Institute of Behavioural Sciences has been a part of International clinical drug trials. Multinational companies like Glaxo Smith Kline, Sanofi Aventis etc. have approved our site for USFDA approved drug trials. These are mainly phase III trials on Dementia, Primary insomnia, Schizophrenia were conducted by the Institute with interesting results.
The team is involved in development of tools and techniques to serve mental health. CIBS has developed its own tools for screening, rating and diagnosis for dementia, depression and school mental health.
CIBS has further moved on to develop a platform for digital mental health and online interventions.